Cellectar Biosciences and Nusano, a physics company transforming the production of radioisotopes, signed a multi-year supply agreement, the company announced recently. According to a release, Nusano will provide Cellectar with…
Archeus Technologies has received FDA clearance for its Investigational New Drug (IND) application for ART-101, a novel receptor-based targeting small molecule developed for the imaging and treatment of prostate cancer,…
Voximetry and Y-mAbs, a commercial-stage biopharmaceutical company focused on the development and commercialization of novel radiopharmaceuticals and commercial-stage antibody-based therapeutic products for the treatment of cancer, have entered into a…
Axio BioPharma and Likarda, a company focused on advanced drug delivery and formulation technologies, announced today a strategic partnership to accelerate innovation in biologic drug development. According to a release,…
Archeus Technologies, a company developing multiple differentiated radiopharmaceutical therapies, and the Wisconsin Alumni Research Foundation (WARF) have entered into a strategic collaboration to advance ART-101, a receptor-based targeting molecule, into…
Forward BIOLABS is expanding to Milwaukee to further strengthen Wisconsin’s biohealth ecosystem for young companies, the organization announced recently. According to a release, these efforts also include expanding Forward BIOLABS’ facility…
Invenra has launched its T-Body™ trispecific antibody platform, a next-generation technology designed to direct correct chain pairing and afford high expression and assembly efficiency in a variety of antibody constructs,…
SHINE Technologies has entered into a definitive agreement to acquire the SPECT business from Lantheus, a radiopharmaceutical-focused company, the company announced recently. Lantheus’ SPECT product portfolio includes imaging agents for…
Invenra launched its B-Body Express Antibody Expression service, which enables biotechnology and pharmaceutical companies to rapidly access the company’s B-Body bispecific antibody platform, the company announced recently. “Advancing bispecific programs…
Promega has partnered with EditCo Bio, a leader in engineered cell solutions, offering high-quality, functionally validated CRISPR-edited cell lines, the company announced recently. “This agreement accelerates scientific innovation by providing…
